We then determined if this resistance was mediated by PD-L1 upregulation, and found that the killing effect of Jurkat cells against MLN4924-pretreated cancer cells was completely restored upon inclusion of anti-PD-L1 antibody (Figs. 4B and S5B). This evidence concerns the gene CD274 and cancer.